Medicine and Dentistry
Breast Cancer
100%
Prostate Cancer
93%
Cancer
60%
Radiation Therapy
47%
Cancer Registry
40%
Malignant Neoplasm
34%
Cohort Analysis
30%
Cancer Mortality
25%
Cancer Risk
24%
Hazard Ratio
23%
Colorectal Carcinoma
23%
Second Cancer
20%
Lung Cancer
18%
Triacylglycerol
18%
Standardized Incidence Ratio
16%
Cancer Therapy
14%
Prostate Specific Antigen
14%
Quality of Life
14%
Mortality Rate
14%
Comorbidity
13%
Relative Survival
13%
Survival Estimate
13%
Pelvic Organ Prolapse
13%
Long Term Survival
12%
Neoplasm
12%
Survival Time
12%
Prostatectomy
11%
Androgen Deprivation Therapy
11%
Outcome Assessment
10%
Gleason Score
10%
Proteus Syndrome
10%
Observational Study
10%
Cancer Diagnosis
10%
Myeloid Leukemia
10%
Prospective Study
9%
Genetic Susceptibility to Cancer
9%
Cancer Cell
9%
Lower Urinary Tract Symptom
9%
Metabolic Syndrome
9%
Fluid Therapy
9%
Prospective Cohort Study
9%
Surgeon
9%
Antidiabetic Agent
9%
Squamous Cell
9%
Gastrointestinal Surgery
9%
Cancer Prognosis
9%
Breast Cancer Survival
9%
Cardiovascular Mortality
9%
Lung Cancer Survival
9%
Sjoegren Syndrome
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
90%
Malignant Neoplasm
41%
Cancer Survival
39%
Colorectal Carcinoma
27%
Breast Cancer
27%
Cancer Mortality
26%
Cancer Registry
22%
Mortality Rate
20%
Second Cancer
18%
Standardized Incidence Ratio
13%
Cohort Study
11%
Androgen
10%
Neoplasm
9%
Lung Cancer
9%
Prospective Study
9%
Triacylglycerol
9%
Sjoegren Syndrome
9%
Non Insulin Dependent Diabetes Mellitus
9%
Pelvic Organ Prolapse
9%
Testis Cancer
9%
Observational Study
9%
Antidiabetic Agent
9%
Squamous Cell Carcinoma
9%
Primary Tumor
9%
Placebo
9%
Uterine Cervix Cancer
9%
Immunotherapy
9%
Colon Carcinoma
8%
Rectum Cancer
8%
Comorbidity
7%
Standardized Mortality Ratio
7%
Nursing and Health Professions
Breast Cancer
54%
Prostate Cancer
45%
Radiotherapy
41%
Cancer Mortality
20%
Glucose Blood Level
18%
Cholesterol Blood Level
18%
Cohort Analysis
18%
Prostatectomy
18%
Malignant Neoplasm
18%
Confidence Interval
17%
Cancer Registry
17%
Hazard Ratio
13%
Triacylglycerol
13%
Comorbidity
10%
Practice Guideline
9%
Female Patient
9%
Triacylglycerol Blood Level
9%
Cardiovascular Mortality
9%
Standardized Mortality Ratio
7%
Disease Severity
7%
Cancer Network
6%
Patient Referral
6%
Clinical Audit
5%
Cardiovascular Disease
5%
